bio.logis GIMS - Home of the Clinical Interpretome
News
| Artikel
Article on "genetic information management systems" for pharmacogenomics in Trillium Diagnostik 2019; 17(1):16
by Daniela Steinberger
Genetisch bedingte Varianten von Proteinen des Medikamentenstoffwechsels können zu unerwünschten oder unzureichenden Arzneimittelwirkungen (UAW) führen. Mindestens 5–10% aller Krankenhauseinweisungen in Europa und Nordamerika sind auf UAW zurückzuführen.
Events
| Konferenz
bio.logis at the 14. Kongress für Gesundheitsnetzwerker, April 2nd & 3rd, Berlin
The key topic of the congress is the Electronic Patient Record (ePA). Several workshops will be devoted to this subject: from the point of view of users and service providers, and as a major political debate on the future and implementation of the ePA.
Testimonials
„We are convinced, that the Diagnostic Report Module of the bio.logis Genetic Information Management Suite will improve the process of creating more valuable results, which we provide to our clients (i.e. physicians). This will help us to build a competition advantage.“
"The Diagnostic Report Module is an enormous help for our scientific experts, who create complex reports on a daily basis. The support we received during the roll-out as well as the willingness and ability to adapt the solutions to our requirements and existing infrastructure are truly excellent."
Participation in EU-Projects within Horizon 2020 program
- Ubiquitous Pharmacogenomics (U-PGx)
- Genetics Clinic of the Future (GCOF)
Partners
